O	0	9	Antishock	Antishock	NN	B-NP
O	10	18	trousers	trouser	NNS	I-NP
O	18	19	:	:	:	O
O	20	21	a	a	DT	B-NP
O	22	32	collective	collective	JJ	I-NP
O	33	39	review	review	NN	I-NP
O	39	40	.	.	.	O

O	41	50	Antishock	Antishock	NN	B-NP
O	51	59	trousers	trouser	NNS	I-NP
O	60	64	have	have	VBP	B-VP
O	65	71	become	become	VBN	I-VP
O	72	74	an	an	DT	B-NP
O	75	83	integral	integral	JJ	I-NP
O	84	88	part	part	NN	I-NP
O	89	91	of	of	IN	B-PP
O	92	101	emergency	emergency	NN	B-NP
O	102	109	medical	medical	JJ	I-NP
O	110	114	care	care	NN	I-NP
O	115	118	for	for	IN	B-PP
O	119	123	many	many	JJ	B-NP
O	124	133	traumatic	traumatic	JJ	I-NP
O	134	137	and	and	CC	I-NP
O	138	142	life	life	NN	I-NP
O	142	143	-	-	HYPH	O
O	143	154	threatening	threaten	VBG	B-VP
O	155	166	emergencies	emergency	NNS	B-NP
O	166	167	.	.	.	O

O	168	172	This	This	DT	B-NP
O	173	180	article	article	NN	I-NP
O	181	191	represents	represent	VBZ	B-VP
O	192	193	a	a	DT	B-NP
O	194	201	summary	summary	NN	I-NP
O	202	204	of	of	IN	B-PP
O	205	208	the	the	DT	B-NP
O	209	216	current	current	JJ	I-NP
O	217	222	state	state	NN	I-NP
O	223	225	of	of	IN	B-PP
O	226	235	knowledge	knowledge	NN	B-NP
O	236	246	concerning	concern	VBG	B-VP
O	247	250	the	the	DT	B-NP
O	251	254	use	use	NN	I-NP
O	255	257	of	of	IN	B-PP
O	258	262	this	this	DT	B-NP
O	263	269	device	device	NN	I-NP
O	269	270	.	.	.	O

O	271	272	A	A	DT	B-NP
O	273	278	brief	brief	JJ	I-NP
O	279	286	history	history	NN	I-NP
O	287	289	of	of	IN	B-PP
O	290	293	the	the	DT	B-NP
O	294	305	development	development	NN	I-NP
O	306	308	of	of	IN	B-PP
O	309	318	antishock	antishock	NN	B-NP
O	319	327	garments	garment	NNS	I-NP
O	328	330	is	be	VBZ	B-VP
O	331	340	discussed	discuss	VBN	I-VP
O	340	341	.	.	.	O

O	342	346	This	This	DT	B-NP
O	347	349	is	be	VBZ	B-VP
O	350	358	followed	follow	VBN	I-VP
O	359	361	by	by	IN	B-PP
O	362	363	a	a	DT	B-NP
O	364	374	discussion	discussion	NN	I-NP
O	375	377	of	of	IN	B-PP
O	378	383	human	human	JJ	B-NP
O	384	392	clinical	clinical	JJ	I-NP
O	393	400	studies	study	NNS	I-NP
O	401	404	and	and	CC	I-NP
O	405	412	results	result	NNS	I-NP
O	413	415	of	of	IN	B-PP
O	416	424	clinical	clinical	JJ	B-NP
O	425	433	research	research	NN	I-NP
O	434	436	on	on	IN	B-PP
O	437	449	hemodynamics	hemodynamic	NNS	B-NP
O	449	450	,	,	,	O
O	451	462	respiration	respiration	NN	B-NP
O	462	463	,	,	,	O
O	464	467	use	use	NN	B-NP
O	468	470	in	in	IN	B-PP
B-Organism_subdivision	471	475	head	head	NN	B-NP
O	476	482	injury	injury	NN	I-NP
O	482	483	,	,	,	O
O	484	487	and	and	CC	O
O	488	495	effects	effect	NNS	B-NP
O	496	498	on	on	IN	B-PP
B-Multi-tissue_structure	499	507	vascular	vascular	JJ	B-NP
O	508	518	hemostasis	hemostasis	NN	I-NP
O	518	519	.	.	.	O

O	520	531	Indications	Indication	NNS	B-NP
O	531	532	,	,	,	O
O	533	550	contraindications	contraindication	NNS	B-NP
O	550	551	,	,	,	O
O	552	565	complications	complication	NNS	B-NP
O	565	566	,	,	,	O
O	567	570	and	and	CC	O
O	571	582	recommended	recommend	VBD	B-VP
O	583	592	procedure	procedure	NN	B-NP
O	593	596	for	for	IN	B-PP
O	597	600	use	use	NN	B-NP
O	601	604	are	be	VBP	B-VP
O	605	614	discussed	discuss	VBN	I-VP
O	614	615	.	.	.	O

O	616	621	Based	Base	VBN	B-PP
O	622	624	on	on	IN	B-PP
O	625	635	randomized	randomize	VBN	B-NP
O	636	647	prospective	prospective	JJ	I-NP
O	648	655	studies	study	NNS	I-NP
O	655	656	,	,	,	O
O	657	666	antishock	antishock	NN	B-NP
O	667	675	garments	garment	NNS	I-NP
O	676	680	have	have	VBP	B-VP
O	681	684	not	not	RB	O
O	684	685	,	,	,	O
O	686	688	as	as	IN	B-SBAR
O	689	692	yet	yet	RB	B-ADVP
O	692	693	,	,	,	O
O	694	698	been	be	VBN	B-VP
O	699	704	shown	show	VBN	I-VP
O	705	707	to	to	TO	I-VP
O	708	715	improve	improve	VB	I-VP
O	716	723	patient	patient	NN	B-NP
O	724	733	morbidity	morbidity	NN	I-NP
O	734	736	or	or	CC	I-NP
O	737	746	mortality	mortality	NN	I-NP
O	746	747	.	.	.	O

O	748	754	Proper	Proper	JJ	B-NP
O	755	758	use	use	NN	I-NP
O	759	761	of	of	IN	B-PP
O	762	771	antishock	antishock	NN	B-NP
O	772	780	garments	garment	NNS	I-NP
O	781	789	requires	require	VBZ	B-VP
O	790	792	an	an	DT	B-NP
O	793	806	understanding	understanding	NN	I-NP
O	807	809	of	of	IN	B-PP
O	810	814	both	both	DT	O
O	815	820	their	their	PRP$	B-NP
O	821	829	function	function	NN	I-NP
O	830	833	and	and	CC	O
O	834	839	their	their	PRP$	B-NP
O	840	851	limitations	limitation	NNS	I-NP
O	851	852	.	.	.	O

